ENTX
Entera Bio Ltd.
Company Overview
| Mkt Cap | $115.07M | Price | $2.91 |
| Volume | 240.72K | Change | +3.19% |
| P/E Ratio | -12.1 | Open | $2.85 |
| Revenue | $181.0K | Prev Close | $2.82 |
| Net Income | $-9.5M | 52W Range | $1.50 - $2.95 |
| Div Yield | N/A | Target | $10.00 |
| Overall | 60 | Value | 45 |
| Quality | 55 | Technical | 81 |
No chart data available
Stock Overview
Updated DailyEntera Bio Ltd. (ENTX) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.91 with a market capitalization of $115.07 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows ENTX with a volume of 241K shares. The stock opened up 1.06% from yesterday's close of $2.82. Current analyst estimates project earnings of $-0.32 per share for this year, with next year targeting $-0.67.
ENTX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ENTX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 243.6%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 02:38 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENTX | $2.91 | +3.2% | 240.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |